Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NATUR-DROGERIET A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   7.1% 7.1% 7.1% 7.1% 7.1% 7.1% 7.1% 7.1%   Bankruptcy risk   1.1% 0.6% 0.6% 2.1% 0.8% 1.8% 9.1% 8.9%   Credit score (0-100)   86 98 97 65 92 71 27 28   Credit rating   A AA AA BBB AA A BB BB   Credit limit (kDKK)   407.9 1,552.9 1,563.3 0.6 1,382.0 7.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   21,282 26,028 26,083 24,003 24,499 23,840 0.0 0.0   EBITDA   1,314 4,978 3,608 -500 4,383 255 0.0 0.0   EBIT   739 4,298 2,931 -1,060 3,907 -223 0.0 0.0   Pre-tax profit (PTP)   394.7 3,997.7 2,560.7 -2,270.7 3,581.0 -690.9 0.0 0.0   Net earnings   273.9 3,099.0 1,973.1 -2,005.7 2,771.1 -553.9 0.0 0.0   Pre-tax profit without non-rec. items   395 3,998 2,561 -2,271 3,581 -691 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   1,695 2,345 1,955 1,763 1,342 1,840 0.0 0.0   Shareholders equity total   6,352 8,851 9,624 6,418 9,189 6,835 5,835 5,835   Interest-bearing liabilities   2,157 1,277 1,106 7,040 3,415 10,232 0.0 0.0   Balance sheet total (assets)   21,830 26,106 26,935 26,467 24,100 27,460 5,835 5,835   Net Debt   1,944 1,184 915 6,983 3,250 10,080 -5,835 -5,835     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   21,282 26,028 26,083 24,003 24,499 23,840 0.0 0.0   Gross profit growth   -3.8% 22.3% 0.2% -8.0% 2.1% -2.7% -100.0% 0.0%   Employees   43 41 42 46 36 39 0 0   Employee growth %   4.9% -4.7% 2.4% 9.5% -21.7% 8.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21,830 26,106 26,935 26,467 24,100 27,460 5,835 5,835   Balance sheet change%   1.1% 19.6% 3.2% -1.7% -8.9% 13.9% -78.8% 0.0%   Added value   1,314.2 4,978.2 3,607.9 -500.5 4,467.4 255.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -460 -31 -1,067 -751 -896 20 -1,840 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.5% 16.5% 11.2% -4.4% 15.9% -0.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.4% 18.0% 11.1% -0.7% 15.7% -0.7% 0.0% 0.0%   ROI %   5.0% 27.2% 17.3% -10.7% 24.8% -1.3% 0.0% 0.0%   ROE %   4.2% 40.8% 21.4% -25.0% 35.5% -6.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   29.2% 33.9% 35.7% 24.2% 38.1% 24.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   147.9% 23.8% 25.4% -1,395.2% 74.1% 3,953.5% 0.0% 0.0%   Gearing %   34.0% 14.4% 11.5% 109.7% 37.2% 149.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   16.7% 17.7% 31.5% 8.9% 6.0% 7.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.0 1.0 1.1 0.7 0.8 0.8 0.0 0.0   Current Ratio   2.2 2.5 2.3 1.7 2.2 1.6 0.0 0.0   Cash and cash equivalent   212.3 93.7 191.2 56.6 164.9 151.7 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   10,924.7 14,252.8 13,955.2 9,987.2 12,304.8 9,114.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   31 121 86 -11 124 7 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   31 121 86 -11 122 7 0 0   EBIT / employee   17 105 70 -23 109 -6 0 0   Net earnings / employee   6 76 47 -44 77 -14 0 0